SuperworthRhythm Pharmaceuticals shares outstanding RYTM
Diluted shares outstanding, averaged over each quarter, from 2016.
- Latest quarter, to Jun 30, 2026
- 68.6M
- On a year earlier
- +7.7%
- more shares
Rhythm Pharmaceuticals had 68.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 7.7% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 66.9M | +9% |
| FY2024 | 61.6M | +4% |
| FY2023 | 59.2M | +5% |
| FY2022 | 56.3M | +12% |
| FY2021 | 50.3M | +14% |
| FY2020 | 44.2M | +5% |
| FY2019 | 42.2M | +23% |
| FY2018 | 34.4M | +31% |
| FY2017 | 26.2M | +157% |
| FY2016 | 10.2M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 68.6M | +8% | |
| Q1 FY26 | 68M | +8% | |
| Q4 FY25 | 66.9M | +9% | |
| Q3 FY25 | 66.3M | +8% | |
| Q2 FY25 | 63.7M | +4% | |
| Q1 FY25 | 63.1M | +5% | |
| Q4 FY24 | 61.6M | +4% | |
| Q3 FY24 | 61.2M | +6% | |
| Q2 FY24 | 61M | +7% | |
| Q1 FY24 | 60.1M | +6% | |
| Q4 FY23 | 59.2M | +5% | |
| Q3 FY23 | 57.9M | +13% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Rhythm Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.